FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2001002914> ?p ?o ?g. }

• W2001002914 endingPage "1024" @default.
• W2001002914 startingPage "1017" @default.
• W2001002914 abstract "In Brief Purpose: The purpose of this study was to assess long-term functional and structural retinal changes in patients with neovascular age-related macular degeneration treated with intravitreal 0.5 mg ranibizumab. Methods: Eighteen patients with neovascular age-related macular degeneration have been evaluated in this retrospective 24-month follow-up study. All patients have been treated with 3 injections of 0.5 mg ranibizumab 1 month apart and retreated according to predefined criteria. At baseline, all patients were subjected to visual acuity, fluorescein angiography, MP1 microperimetry, and Stratus optical coherence tomography. Although visual acuity and optical coherence tomography were repeated 28 ± 2 days after each injection, MP1 was performed at 6, 12, and 24 months. Results: Seventeen of 18 and 14 of 18 patients completed 12 and 24 months of follow-up, respectively. Mean retinal sensitivity significantly improved from 3.89 ± 3.0 dB to 7.33 ± 4.11 dB at 24 months (P = 0.024). Mean visual acuity improved from 48.67 ± 8.59 to 59.17 ± 16.45 at 24 months (P = 0.049). Visual acuity improved to ≥15 letters in 33.3% (6 of 18) of patients and <15 letters in 44.4% (8 of 18); 22.2% (4 of 18) of patients lost <15 letters at 24 months. Five of 13 patients (38.5%) with either an instable or relatively instable fixation at baseline showed improvement of fixation stability at 24 months. Central retinal thickness significantly decreased from 310.5 ± 85.7 to 232.9 ± 60.1 at 24 months (P = 0.0001). Conclusion: Intravitreal injections of 0.5 mg ranibizumab determine progressive improvement of retinal sensitivity until 24 months, although visual acuity levels off after 6 months, suggesting that microperimetry may give additional information about macular function not given by visual acuity alone. Intravitreal injections of 0.5 mg ranibizumab determine progressive improvement of retinal sensitivity until 24 months, although visual acuity levels off after 6 months, suggesting that microperimetry may give additional information about macular function not given by visual acuity alone." @default.
• W2001002914 created "2016-06-24" @default.
• W2001002914 creator A5012276258 @default.
• W2001002914 creator A5021292859 @default.
• W2001002914 creator A5022647583 @default.
• W2001002914 creator A5036543677 @default.
• W2001002914 creator A5048150233 @default.
• W2001002914 creator A5060427599 @default.
• W2001002914 creator A5075121596 @default.
• W2001002914 date "2010-07-01" @default.
• W2001002914 modified "2023-09-26" @default.
• W2001002914 title "RETINAL FUNCTIONAL CHANGES MEASURED BY MICROPERIMETRY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED WITH RANIBIZUMAB" @default.
• W2001002914 cites W109974915 @default.
• W2001002914 cites W127872553 @default.
• W2001002914 cites W1487528435 @default.
• W2001002914 cites W1539571840 @default.
• W2001002914 cites W1601975653 @default.
• W2001002914 cites W1802218256 @default.
• W2001002914 cites W1972242350 @default.
• W2001002914 cites W1977060039 @default.
• W2001002914 cites W1981166344 @default.
• W2001002914 cites W1993244458 @default.
• W2001002914 cites W1995086395 @default.
• W2001002914 cites W1999846890 @default.
• W2001002914 cites W2024093256 @default.
• W2001002914 cites W2041759932 @default.
• W2001002914 cites W2042321005 @default.
• W2001002914 cites W2044913417 @default.
• W2001002914 cites W2074798063 @default.
• W2001002914 cites W2075984382 @default.
• W2001002914 cites W2077985567 @default.
• W2001002914 cites W2080983752 @default.
• W2001002914 cites W2084683760 @default.
• W2001002914 cites W2085402595 @default.
• W2001002914 cites W2085712747 @default.
• W2001002914 cites W2086186570 @default.
• W2001002914 cites W2086452924 @default.
• W2001002914 cites W2088148914 @default.
• W2001002914 cites W2124415048 @default.
• W2001002914 cites W2133402856 @default.
• W2001002914 cites W2141972913 @default.
• W2001002914 cites W2328954905 @default.
• W2001002914 cites W95972928 @default.
• W2001002914 doi "https://doi.org/10.1097/iae.0b013e3181cfd3c6" @default.
• W2001002914 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20224469" @default.
• W2001002914 hasPublicationYear "2010" @default.
• W2001002914 type Work @default.
• W2001002914 sameAs 2001002914 @default.
• W2001002914 citedByCount "47" @default.
• W2001002914 countsByYear W20010029142012 @default.
• W2001002914 countsByYear W20010029142013 @default.
• W2001002914 countsByYear W20010029142014 @default.
• W2001002914 countsByYear W20010029142015 @default.
• W2001002914 countsByYear W20010029142017 @default.
• W2001002914 countsByYear W20010029142018 @default.
• W2001002914 countsByYear W20010029142019 @default.
• W2001002914 countsByYear W20010029142020 @default.
• W2001002914 countsByYear W20010029142021 @default.
• W2001002914 countsByYear W20010029142022 @default.
• W2001002914 countsByYear W20010029142023 @default.
• W2001002914 crossrefType "journal-article" @default.
• W2001002914 hasAuthorship W2001002914A5012276258 @default.
• W2001002914 hasAuthorship W2001002914A5021292859 @default.
• W2001002914 hasAuthorship W2001002914A5022647583 @default.
• W2001002914 hasAuthorship W2001002914A5036543677 @default.
• W2001002914 hasAuthorship W2001002914A5048150233 @default.
• W2001002914 hasAuthorship W2001002914A5060427599 @default.
• W2001002914 hasAuthorship W2001002914A5075121596 @default.
• W2001002914 hasConcept C118487528 @default.
• W2001002914 hasConcept C141071460 @default.
• W2001002914 hasConcept C146249460 @default.
• W2001002914 hasConcept C2776403814 @default.
• W2001002914 hasConcept C2776694085 @default.
• W2001002914 hasConcept C2777802072 @default.
• W2001002914 hasConcept C2778257484 @default.
• W2001002914 hasConcept C2779100554 @default.
• W2001002914 hasConcept C2780248432 @default.
• W2001002914 hasConcept C2780827179 @default.
• W2001002914 hasConcept C2781100027 @default.
• W2001002914 hasConcept C2908647359 @default.
• W2001002914 hasConcept C71924100 @default.
• W2001002914 hasConcept C99454951 @default.
• W2001002914 hasConceptScore W2001002914C118487528 @default.
• W2001002914 hasConceptScore W2001002914C141071460 @default.
• W2001002914 hasConceptScore W2001002914C146249460 @default.
• W2001002914 hasConceptScore W2001002914C2776403814 @default.
• W2001002914 hasConceptScore W2001002914C2776694085 @default.
• W2001002914 hasConceptScore W2001002914C2777802072 @default.
• W2001002914 hasConceptScore W2001002914C2778257484 @default.
• W2001002914 hasConceptScore W2001002914C2779100554 @default.
• W2001002914 hasConceptScore W2001002914C2780248432 @default.
• W2001002914 hasConceptScore W2001002914C2780827179 @default.
• W2001002914 hasConceptScore W2001002914C2781100027 @default.
• W2001002914 hasConceptScore W2001002914C2908647359 @default.
• W2001002914 hasConceptScore W2001002914C71924100 @default.
• W2001002914 hasConceptScore W2001002914C99454951 @default.
• W2001002914 hasIssue "7" @default.
• W2001002914 hasLocation W20010029141 @default.

• next